Cystic Fibrosis — Research Summary
Printed from RareWays (rareways.com.au) on 10 September 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Comment on "Prevalence, type, and clinical implications of CFTR variants in bronchiectasis".
Priya Shanvi et al. — Pulmonology (1 December 2026)
https://pubmed.ncbi.nlm.nih.gov/41684272/
- 2.
Correspondence: 'CFTR variants in bronchiectasis'.
Yang Yuanli — Pulmonology (1 December 2026)
https://pubmed.ncbi.nlm.nih.gov/41696981/
- 3.
From CFTR genotype enrichment to functional and longitudinal endotyping in Bronchiectasis.
Tian Changping et al. — Pulmonology (1 December 2026)
https://pubmed.ncbi.nlm.nih.gov/42212955/
- 4.
A feasibility pilot trial to deliver a virtual intervention for promoting daily self-management in adolescents and young adults with cystic fibrosis: A brief report of tele-coach outcomes.
Lindwall Jennifer J et al. — PEC innovation (1 December 2026)
https://pubmed.ncbi.nlm.nih.gov/42305635/
- 5.
Early and mature
Jean-Pierre Vincent et al. — Biofilm (1 December 2026)
https://pubmed.ncbi.nlm.nih.gov/42358622/
Clinical Trials — Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials.
- 1.
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
Recruiting — Phase 2 — CSL Behring
https://clinicaltrials.gov/study/NCT07048262
- 2.
Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.
Recruiting — Phase 1 — Sionna Therapeutics Inc.
https://clinicaltrials.gov/study/NCT07035990
- 3.
Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis
Recruiting — Phase 1 — Cystetic Medicines, Inc.
https://clinicaltrials.gov/study/NCT05802264
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Cystic Fibrosis
Cystic fibrosis is a genetic condition that causes thick, sticky mucus to build up in the lungs and digestive system. It affects breathing and digestion. Treatments have advanced significantly, and many people with CF now live into adulthood and beyond.
Most Recent Research
Common Questions
What is Cystic Fibrosis?
Cystic fibrosis is a genetic condition that causes thick, sticky mucus to build up in the lungs and digestive system. It affects breathing and digestion. Treatments have advanced significantly, and many people with CF now live into adulthood and beyond.
How many clinical trials are available for Cystic Fibrosis?
RareWays currently indexes 1338 clinical trials for Cystic Fibrosis, of which 157 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.
Where does the research data for Cystic Fibrosis come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Cystic Fibrosis.
No spam. Unsubscribe any time. Not medical advice.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.